Evidence map›Paper›PMID 19458250›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2009

Single-cell imaging of retinal ganglion cell apoptosis with a cell-penetrating, activatable peptide probe in an in vivo glaucoma model.

Edward M Barnett, Xu Zhang, Dustin Maxwell, Qing Chang, David Piwnica-Worms

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
13.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 130 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Chemically Driven Rotatory Molecular Machines.Angewandte Chemie (International ed. in English) · 2022
    Review
  6. Article
  7. Review
  8. Article
  9. Imaging Retinal Ganglion Cell Death and Dysfunction in Glaucoma.International ophthalmology clinics · 2019
    Review
  10. Article
  11. Article
  12. In vivo retinal and choroidal hypoxia imaging using a novel activatable hypoxia-selective near-infrared fluorescent probe.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2016
    Article
  13. Article
  14. Reporter nanoparticle that monitors its anticancer efficacy in real time.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Chemical science · 2015
    Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Edward M BarnettDepartment of Ophthalmology and Visual Sciences, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, MO 63110, USA.
Xu Zhang
Dustin Maxwell
Qing Chang
David Piwnica-Worms
Mallinckrodt (United States) · US

Funding

WU-MDACC Inter-Institutional Molecular Imaging CenterP50CA094056 · NCI · WASHINGTON UNIVERSITY · PI KOPAN, RAPHAEL · 2002 to 2016
$26.3M
WASHINGTON UNIVERSITY CENTER VISION RESEARCHP30EY002687 · NEI · WASHINGTON UNIVERSITY · PI Philip Andrew Ruzycki · 1985 to 2026
$18.4M
MEMBRANE PERMEANT PEPTIDES FOR IMAGING CELL FUNCTIONR01CA082841 · NCI · WASHINGTON UNIVERSITY · PI PIWNICA-WORMS, DAVID · 1999 to 2008
$3.0M
In Vivo Imaging of Retinal Apoptosis Using Activatable Permeation PeptidesR21EY017636 · NEI · WASHINGTON UNIVERSITY · PI BARNETT, EDWARD MICHAEL · 2006 to 2007
$413k
NCI NIH HHS CA 82841NCI NIH HHS P50 CA094056NCI NIH HHS P50 CA94056NCI NIH HHS R01 CA082841NEI NIH HHS P30 EY002687NEI NIH HHS P30 EY 02687NEI NIH HHS R21 EY017636
6 · The paper itself

Abstract

Molecular imaging probes have potential for in vivo identification of apoptosis and other intracellular processes. TcapQ, a cell-penetrating, near-infrared fluorescent peptide probe designed to be optically silent through intramolecular fluorescence quenching and activated by effector caspases, has been previously described and validated in vitro. Herein, using NMDA-induced apoptosis of retinal ganglion cells (RGCs), representing an in vivo rat model of glaucoma, we assessed the ability of TcapQ to image single-cell apoptosis through effector caspase activity. Following intravitreal injection, intracellular TcapQ activation occurred specifically in RGCs, identified individual apoptotic cells, showed a clear dose-response relationship with NMDA, and colocalized with TUNEL labeling in the retina. There was a significant diminution of probe activation following pretreatment with a specific inhibitor of caspase-3. Stereospecificity was also exhibited by the lack of intracellular fluorescence upon administration of the noncleavable isomer, dTcapQ. TcapQ has potential utility in detecting and monitoring single-cell apoptosis in glaucoma in vivo.

Indexed as

AnimalsApoptosisCytological TechniquesGlaucomaIn Situ Nick-End LabelingMaleN-MethylaspartatePeptidesRatsRetinal Ganglion CellsN-MethylaspartatePeptidesTcapQ647 peptide

Identifiers

PMID19458250
PMCPMC2695102
OpenAlexW2121134942

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.